RYLD ETF

$15.27
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing 10 of 11 holdings(as of Jan 30, 2026)Top 10 Weight: 101.07%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1RSSLGlobal X Russell 2000 Etf101.01%12,881,961$1.31B••••••••••••••••••••••
2-Cash0.11%1,453,143$1.45M••••••••••••••••••••••
3INBXInhibrx Inc0.00%15,798$10.3K••••••••••••••••••••••
4OABIOmniab Inc 12.5 Earnout0.00%2,421-••••••••••••••••••••••
5PLSEPulse Biosciences Inc0.00%1,148$2.4K••••••••••••••••••••••
6RNACCartesian Therapeutics Inc0.00%1-••••••••••••••••••••••
7RAINRain Oncology Inc0.00%1-••••••••••••••••••••••
8-Canadian Dollar0.00%7,088$5.2K••••••••••••••••••••••
9-Novartis Ag - Cvr0.00%26,043$10.2K••••••••••••••••••••••
10-Other Payable & Receivables-0.05%-651,597$-651597••••••••••••••••••••••
Want to see all 11 holdings?View All HoldingsPRO

Top Holdings Themes

SemiconductorsNetworking InfrastructureMedical DevicesBiotechnologyOncology

RYLD ETF Top Holdings

RYLD holdings top 10 positions. The top 10 holdings account for 101.1% of the fund, led by Global X Russell 2000 Etf at 101.0%, Cash at 0.1%, Inhibrx Inc at 0.0%.

RYLD portfolio concentration is relatively high, with the top 10 representing 101.1% of total assets. The largest sector exposure is Unknown at 101.0%.

RYLD sector allocation provides a detailed breakdown. RYLD overlap tool shows how holdings compare to other funds in your portfolio.

Showing 10 of 11 holdingsTop 10 Weight: 101.07%
#TickerNameIndustryWeightAllocation
1RSSLGlobal X Russell 2000 EtfUnknown101.01%
2-CashOther0.11%
3INBXInhibrx IncUnknown-
4OABIOmniab Inc 12.5 EarnoutHealth Care-
5PLSEPulse Biosciences IncHealth Care-
6RNACCartesian Therapeutics IncUnknown-
7RAINRain Oncology IncUnknown-
8-Canadian DollarOther-
9-Novartis Ag - CvrOther-
10-Other Payable & ReceivablesOther-0.05%
Want to see all 11 holdings?

Holdings Distribution

Loading chart...